Is Travere Therapeutics, Inc. (TVTX) a Buy, Sell, or Hold?
NASDAQ : TVTX
Travere Therapeutics, Inc. — Competitors
$55.89 USD
-$1.39 (-2.43%)
- Volume
- 1.5M
- Average Volume
- 2.08M
- Market Capitalization
- $5.2B
- P/E Ratio
- -114.06
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $60.10
- Year Low
- $15.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
TVTX vs. The Competition
| Properties | TVTX | AAPG | APGE | CELC |
|---|---|---|---|---|
| Market Cap | $5.2B | $1.62B | $8.3B | $4.21B |
| Shares Outstanding | $92.99M | $92.96M | $61.88M | $48.77M |
| P/E Ratio | -114.06 | -8.5 | -30.97 | -22.21 |
| EPS | -0.23 | -13.29 | -3.94 | -3.54 |
| Day Low | 55.34 | 17.2401 | 134.05 | 85.46 |
| Day High | 57.55 | 17.6 | 134.37 | 88.5 |
| Year Low | 15.03 | 16.36 | 34.34 | 38 |
| Year High | 60.1 | 48.45 | 134.46 | 151.02 |
| Average Price 50 | 53.083 | 18.47554 | 112.7672 | 100.539 |
| Average Price 200 | 38.36148 | 24.87754 | 82.9341 | 103.7226 |
| Volume | 1.5M | 3720 | 1.7M | 677.93K |
| Average Volume | - | - | - | - |